Patient with stage 3 dry AMD OD. This patient would be a good candidate for AREDS 2 supplementation as well as genetic testing.

An old choroidal neovascular membrane in a patient’s right eye prior to advent of anti-VEGF agents. At that time, no treatment was available.

Same patient as Figure B. Second eye developed exudative AMD several years later, and patient went on to have serial anti-VEGF injections OS.

Example of a patient with wet AMD. This patient went on to have serial anti-VEGF injections OD.